πŸ‡ΊπŸ‡Έ FDA
Patent

US 9977033

Methods for assessing cancer recurrence

granted A61KA61K31/137A61K31/337

Quick answer

US patent 9977033 (Methods for assessing cancer recurrence) held by The Board of Regents of the University of Texas System expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/137, A61K31/337, A61K31/573, A61K31/58